How much revenue does Indoco Remedies make?

Indoco Remedies reported 17.93 billion INR in revenue for fiscal year 2026.

Where does Indoco Remedies make most of its revenue?

India: 66% of revenue by region in fiscal year 2025, followed by Outside India (34%).

What companies are similar to Indoco Remedies?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Syncom Formulations (India) Limited (SYNCOMF.NS), Venus Remedies Limited (VENUSREM.NS), Panacea Biotec Limited (PANACEABIO.NS), Sakar Healthcare Limited (SAKAR.NS).

Indoco Remedies Limited (INDOCO.NS) Stock

About Indoco Remedies Limited

Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides bran...

At a glance

Indoco Remedies reported revenue of 17.93 billion INR for fiscal year 2026, and net income of -951.50 million INR. India was its largest region in fiscal year 2025, with 66% of revenue.

Figures from company filings; latest fiscal year ended March 31, 2026.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.